Perego, Eleonora http://orcid.org/0000-0002-1700-584X
Zappone, Sabrina http://orcid.org/0000-0003-2695-4999
Castagnetti, Francesco
Mariani, Davide http://orcid.org/0000-0003-0903-5632
Vitiello, Erika
Rupert, Jakob
Zacco, Elsa http://orcid.org/0000-0002-3593-6023
Tartaglia, Gian Gaetano http://orcid.org/0000-0001-7524-6310
Bozzoni, Irene
Slenders, Eli http://orcid.org/0000-0002-6757-1372
Vicidomini, Giuseppe http://orcid.org/0000-0002-3085-730X
Funding for this research was provided by:
Compagnia di San Paolo (EPFD0098)
EC | Horizon 2020 Framework Programme (754490)
Associazione Italiana per la Ricerca sul Cancro (23053)
European Research Council - CoG National Center for Gene Therapy and Drugs based on RNA Technology European Research Council - ERC-SyG NextGeneration EU PNRR
Article History
Received: 15 May 2023
Accepted: 24 November 2023
First Online: 12 December 2023
Competing interests
: G.V. has a personal financial interest (co-founder) in Genoa Instruments, Italy. G.V. has any non-financial interests. The remaining authors declare no competing interests (financial or non-financial).